C. Michael White, Pharm.D.
C. Michael White, Pharm.D.
University of Connecticut, Pharmacy Practice
Geverifieerd e-mailadres voor uconn.edu - Homepage
Geciteerd door
Geciteerd door
Statins and cancer risk: a meta-analysis
KM Dale, CI Coleman, NN Henyan, J Kluger, CM White
Jama 295 (1), 74-80, 2006
Effect of statins on skeletal muscle function
BA Parker, JA Capizzi, AS Grimaldi, PM Clarkson, SM Cole, J Keadle, ...
Circulation 127 (1), 96-103, 2013
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
M Tomaszewski, C White, P Patel, N Masca, R Damani, J Hepworth, ...
Heart 100 (11), 855-861, 2014
Understanding heterogeneity in meta‐analysis: the role of meta‐regression
WL Baker, C Michael White, JC Cappelleri, J Kluger, CI Coleman, ...
International journal of clinical practice 63 (10), 1426-1434, 2009
Biological variation for N-terminal pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure
AHB Wu, A Smith, S Wieczorek, JF Mather, B Duncan, CM White, C McGill, ...
The American journal of cardiology 92 (5), 628-631, 2003
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
SA Shah, S Sander, CM White, M Rinaldi, CI Coleman
The Lancet infectious diseases 7 (7), 473-480, 2007
The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
EL Gillespie, CM White, M Kardas, M Lindberg, CI Coleman
Diabetes care 28 (9), 2261-2266, 2005
Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review
AV Hernandez, YM Roman, V Pasupuleti, JJ Barboza, CM White
Annals of internal medicine 173 (4), 287-296, 2020
A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin
CM White
The Journal of Clinical Pharmacology 42 (9), 963-970, 2002
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial
S Giri, CM White, AB Dunn, K Felton, L Freeman-Bosco, P Reddy, ...
The Lancet 357 (9259), 830-836, 2001
Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a …
DM Sobieraj, ER Weeda, E Nguyen, CI Coleman, CM White, SC Lazarus, ...
Jama 319 (14), 1485-1496, 2018
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis
WL Baker, R Talati, CM White, CI Coleman
Diabetes research and clinical practice 87 (1), 98-107, 2010
Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis
KM Reinhart, CI Coleman, C Teevan, P Vachhani, CM White
Annals of Pharmacotherapy 42 (12), 1766-1771, 2008
Effect of cinnamon on glucose control and lipid parameters
WL Baker, G Gutierrez-Williams, CM White, J Kluger, CI Coleman
Diabetes care 31 (1), 41-43, 2008
A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy
BA Taylor, L Lorson, CM White, PD Thompson
Atherosclerosis 238 (2), 329-335, 2015
A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential
CM White
The Journal of Clinical Pharmacology 59 (7), 923-934, 2019
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure
S Sander, CI Coleman, AA Patel, J Kluger, CM White
Journal of cardiac failure 12 (6), 464-472, 2006
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
B Williams, TM MacDonald, SV Morant, DJ Webb, P Sever, GT McInnes, ...
The lancet Diabetes & endocrinology 6 (6), 464-475, 2018
The effects of barley-derived soluble fiber on serum lipids
R Talati, WL Baker, MS Pabilonia, CM White, CI Coleman
The Annals of Family Medicine 7 (2), 157-163, 2009
The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases
HMA Abraham, CM White, WB White
Drug safety 38, 33-54, 2015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20